miR-145 inhibits invasion and metastasis by directly targeting Smad3 in nasopharyngeal cancer. (Q38921152)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25578496%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

miR-145 inhibits invasion and metastasis by directly targeting Smad3 in nasopharyngeal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25578496%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25578496%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Haiping Huang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25578496%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Peng Sun

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25578496%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Zhe Lei

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25578496%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Manyi Li

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25578496%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Yihong Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25578496%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Jisheng Liu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25578496%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

publication date

13 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25578496%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25578496%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25578496%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25578496%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

4123-4131

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25578496%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

The aetiology of nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

MicroRNAs: small RNAs with a big role in gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

Ribo-gnome: the big world of small RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

The proto-oncogene ERG is a target of microRNA miR-145 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

Overexpression of miR-145 increases the sensitivity of vemurafenib in drug-resistant colo205 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

The effect of transforming growth factor-beta1 on nasopharyngeal carcinoma cells: insensitive to cell growth but functional to TGF-beta/Smad pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

Targeting Smad2 and Smad3 by miR-136 suppresses metastasis-associated traits of lung adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

TGFβ-induced invasion of prostate cancer cells is promoted by c-Jun-dependent transcriptional activation of Snail1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

Upregulated SMAD3 promotes epithelial-mesenchymal transition and predicts poor prognosis in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

Modulation of microRNA processing by p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

Resveratrol Impedes the Stemness, Epithelial-Mesenchymal Transition, and Metabolic Reprogramming of Cancer Stem Cells in Nasopharyngeal Carcinoma through p53 Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

Human RNA methyltransferase BCDIN3D regulates microRNA processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

SMAD proteins control DROSHA-mediated microRNA maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3046-6

Down-regulation of activin, activin receptors, and Smads in high-grade breast cancer.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25578496